Product Details:
| Minimum Order Quantity | 1 Vial |
| Packaging Type | Vial |
| Brand | Neoben50 |
| Pack Size | 1*5 ml |
| Manufacturer | Neon Labs |
| Shelf Life | 24 Months |
Vinorelbine Injection is a semi-synthetic vinca alkaloid chemotherapy used primarily to treat non-small cell lung cancer and advanced breast cancer. It works by inhibiting microtubule formation, disrupting cancer cell division and growth. Administered intravenously, it's essential for targeted, systemic cancer therapy.
Product Details:
| Minimum Order Quantity | 1 Vial |
| Strength | 50 mg |
| Packaging Type | Vial |
| Brand | Fludacel 50 |
| Shelf Life | 24 Months |
| Form | Injection |
Fludarabine Phosphate Injection is a purine analog used in treating chronic lymphocytic leukemia and certain lymphomas. It inhibits DNA synthesis, leading to cancer cell death. Its precision in targeting malignant cells makes it a key agent in hematologic malignancy management and bone marrow conditioning regimens.
Product Details:
| Minimum Order Quantity | 1 Vial |
| Strength | 50 mg |
| Packaging Type | Vial |
| Brand | Fludocyte 50 |
| Manufacturer | Intas |
| Shelf Life | 36 Months |
Fludarabine Phosphate Injection is a purine analog used in treating chronic lymphocytic leukemia and certain lymphomas. It inhibits DNA synthesis, leading to cancer cell death. Its precision in targeting malignant cells makes it a key agent in hematologic malignancy management and bone marrow conditioning regimens.
Product Details:
| Minimum Order Quantity | 1 Vial |
| Strength | 50 mg |
| Packaging Type | Vial |
| Brand | Emmdara |
| Manufacturer | Emcure |
| Shelf Life | 24 Months |
Fludarabine Phosphate Injection is a purine analog used in treating chronic lymphocytic leukemia and certain lymphomas. It inhibits DNA synthesis, leading to cancer cell death. Its precision in targeting malignant cells makes it a key agent in hematologic malignancy management and bone marrow conditioning regimens.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 20 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cabotib 60 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cabotib 40 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cabotib |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 20 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cabotres 20 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cabotres 40 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Shelf Life | Cabotres 60 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cabozanib 20 |
| Strength | 20 mg |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cabozanib 40 |
| Sheld Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cabozanib 60 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cazanat 60 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cazanat 40 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 20 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cazanat 20 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cobolong 60 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Shelf Life | 24 Months |
| Brand | Cobolong 60 |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 20 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cobolong 20 |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cabometyx |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Brand | Cabometyx |
| Shelf Life | 24 Months |
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 28 Tablets |
| Strength | 40 mg |
| Packaging Type | Bottle |
| Brand | Regolieva |
| Shelf Life | 24 Months |
Regorafenib Tablets are oral multikinase inhibitors used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. They block tumor angiogenesis and cell proliferation by targeting multiple kinases, thereby slowing disease progression and improving survival in advanced-stage cancers.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 28 Tablets |
| Strength | 40 mg |
| Packaging Type | Bottle |
| Brand | RegDual |
| Shelf Life | 24 Months |
Regorafenib Tablets are oral multikinase inhibitors used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. They block tumor angiogenesis and cell proliferation by targeting multiple kinases, thereby slowing disease progression and improving survival in advanced-stage cancers.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 28 Tablets |
| Strength | 40 mg |
| Packaging Type | Bottle |
| Brand | Resihance |
| Shelf Life | 24 Months |
Regorafenib Tablets are oral multikinase inhibitors used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. They block tumor angiogenesis and cell proliferation by targeting multiple kinases, thereby slowing disease progression and improving survival in advanced-stage cancers.
Product Details:
| Minimum Order Quantity | 3 Bottle |
| Packaging size | 28 Tablets per bottle |
| Manufacturer | Natco |
| Treatment | Advanced hepatocellular carcinoma and Stomach Cancer |
| Prescription/Non prescription | Prescription |
| Brand | Regonat |
| Dose Strength | 40mg |
| Composition | Regorafenib |
| Form | Tablet |
Regorafenib Tablets are oral multikinase inhibitors used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. They block tumor angiogenesis and cell proliferation by targeting multiple kinases, thereby slowing disease progression and improving survival in advanced-stage cancers.
Product Details:
| Strength | 100 mg |
| Manufacturer | Cipla |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 20 mg |
| Manufacturer | Dr.Reddy's |
| Shelf Life | 24 Months |
| Pack Type | Bottle |
| Pack Size | 1*5 |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Manufacturer | Dr.Reddy's |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
| Strength | 250 mg |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 250 mg |
| Manufacturer | Dr.Reddy's |
| Shelf Life | 24 Months |
| Pack Type | Bottle |
| Pack Size | 1*5 |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 250 mg |
| Manufacturer | Hetero Healthcare |
| Shelf Life | 36 Months |
| Pack Size | 1*5 |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 100 mg |
| Manufacturer | Hetero Healthcare |
| Shelf Life | 36 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 20 mg |
| Manufacturer | Hetero Healthcare |
| Shelf Life | 36 Months |
| Pack Size | 1*5 |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 250 mg |
| Manufacturer | Emcure |
| Shelf Life | 24 |
| Storage Instruction | Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 100 mg |
| Manufacturer | Emcure |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 250 mg |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
| Manufacturer | Natco |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 250 mg |
| Manufacturer | Cipla |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 20 mg |
| Manufacturer | Cipla |
| Shelf Life | 24 Months |
| Pack Size | 1*5 |
| Pack Type | Bottle |
| MOQ | 1 Box |
Temozolomide Capsules are potent oral chemotherapy drugs used primarily to treat brain cancers like glioblastoma multiforme and anaplastic astrocytoma. They work by damaging cancer cell DNA, preventing growth and replication, offering improved survival and disease control in aggressive tumors.
Product Details:
| Strength | 1 mg/ 1ml |
| Packaging Type | Vial |
| Brand | Biocristin-AQ |
| Manufacturer | Zydus |
| Shelf Life | 24 Months |
| MOQ | 1 Box |
Vincristine Sulphate Injection is a potent chemotherapy agent used to treat various cancers, including leukemia, lymphoma, and solid tumors. It disrupts cancer cell division by inhibiting microtubule formation, slowing tumor growth. Administered intravenously, it's essential in multi-drug cancer treatment regimens.
Product Details:
| Strength | 1 mg/ 1ml |
| Packaging Type | Vial |
| Brand | Onvinc |
| Manufacturer | Neon |
| Shelf Life | 24 Months |
| MOQ | 1 Box |
Vincristine Sulphate Injection is a potent chemotherapy agent used to treat various cancers, including leukemia, lymphoma, and solid tumors. It disrupts cancer cell division by inhibiting microtubule formation, slowing tumor growth. Administered intravenously, it's essential in multi-drug cancer treatment regimens.
Product Details:
| Strength | 1 mg/ 1ml |
| Packaging Type | Vial |
| Brand | VINLON 1 |
| Manufacturer | Celon Labs |
| Shelf Life | 24 Months |
| MOQ | 1 Box |
Vincristine Sulphate Injection is a potent chemotherapy agent used to treat various cancers, including leukemia, lymphoma, and solid tumors. It disrupts cancer cell division by inhibiting microtubule formation, slowing tumor growth. Administered intravenously, it's essential in multi-drug cancer treatment regimens.